Outcomes and resource utilization in calcium pyrophosphate deposition disease patients who underwent total knee arthroplasty: a cross-sectional analysis
- PMID: 35175448
- DOI: 10.1007/s10067-022-06101-6
Outcomes and resource utilization in calcium pyrophosphate deposition disease patients who underwent total knee arthroplasty: a cross-sectional analysis
Abstract
This cross-sectional study aims to evaluate the predictors, outcomes, and resource utilization of total knee arthroplasty (TKA) in calcium pyrophosphate deposition disease (CPPD) patients. We used the US National Inpatient Sample database to identify CPPD and non-CPPD who underwent TKA from 2006 to 2014. Data collection included patient demographics and comorbidities. Outcomes following TKA included in-hospital mortality, complications, length of hospitalization, hospital charges, and disposition. Among the 5,564,005 patients who have undergone TKA, 11,529 (0.20%) had CPPD, with a median age of 72 years, and 53.7% were females. Compared with non-CPPD, patients with CPPD were more likely to be older (mean 72 vs 66 years; p < 0.001), male, white, and have Medicare insurance. CPPD patients were more likely to have ≥ 2 comorbidities calculated by the Charlson Comorbidity Index and discharge to an inpatient/rehabilitation facility. Regarding inpatient complications, myocardial infarction and knee reoperation were significantly more common in CPPD patients. TKA in CPPD patients was associated with significantly higher odds of increased length of stay (> 3 days) than those without CPPD (OR 1.43, 95% CI 1.37-1.49). There was no significant difference in the in-hospital mortality even after adjusting for possible confounders. CPPD patients who underwent TKA were more likely to have a longer hospital stay and discharge to a non-home setting than non-CPPD. Also, CPPD patients had a higher comorbidity burden and risk for myocardial infarction and reoperation.Key Points• This is the largest study to analyze data of CPPD patients who underwent TKA and compare them with non-CPPD patients, using a large nationwide database.• Compared to non-CPPD patients, TKA in CPPD patients is associated with a greater length of stay and disposition to a nursing/rehabilitation facility.• In-hospital complications such as myocardial infarction and reoperation were more frequently observed in CPPD patients than non-CPPD.• The results of this study should alert healthcare providers to develop strategies in order to improve outcomes of CPPD patients undergoing TKA.
Keywords: Calcium pyrophosphate; Chondrocalcinosis; Healthcare utilization; Knee arthroplasty; Knee replacement; Patient outcome assessment.
© 2022. International League of Associations for Rheumatology (ILAR).
Similar articles
-
Outcomes of total hip arthroplasty in calcium pyrophosphate deposition disease patients.Semin Arthritis Rheum. 2023 Dec;63:152300. doi: 10.1016/j.semarthrit.2023.152300. Epub 2023 Nov 4. Semin Arthritis Rheum. 2023. PMID: 37931491
-
Acute coronary syndrome in calcium pyrophosphate deposition disease patients: A US inpatient care cohort study.Semin Arthritis Rheum. 2024 Aug;67:152464. doi: 10.1016/j.semarthrit.2024.152464. Epub 2024 May 17. Semin Arthritis Rheum. 2024. PMID: 38820918
-
Does chondrocalcinosis affect Knee Society scores and range of motion after TKA?Clin Orthop Relat Res. 2014 May;472(5):1512-7. doi: 10.1007/s11999-013-3447-z. Epub 2014 Jan 3. Clin Orthop Relat Res. 2014. PMID: 24385044 Free PMC article.
-
Factors associated with hospital stay length, discharge destination, and 30-day readmission rate after primary hip or knee arthroplasty: Retrospective Cohort Study.Orthop Traumatol Surg Res. 2019 Sep;105(5):949-955. doi: 10.1016/j.otsr.2019.04.012. Epub 2019 Jun 15. Orthop Traumatol Surg Res. 2019. PMID: 31208932 Review.
-
Temporal Trends and Predictors of Thirty-Day Readmissions and Emergency Department Visits Following Total Knee Arthroplasty in Ontario Between 2003 and 2016.J Arthroplasty. 2020 Feb;35(2):364-370. doi: 10.1016/j.arth.2019.09.015. Epub 2019 Sep 14. J Arthroplasty. 2020. PMID: 31732370 Review.
Cited by
-
An Update on the Diagnosis and Management of Calcium Crystal Disease.Curr Rheumatol Rep. 2023 Aug;25(8):145-151. doi: 10.1007/s11926-023-01106-9. Epub 2023 May 30. Curr Rheumatol Rep. 2023. PMID: 37249830 Free PMC article. Review.
-
Synovium to Myocardium: A Case of Calcium Pyrophosphate Dihydrate Crystal Arthritis Associated With Myocardial Infarction.Cureus. 2023 Feb 1;15(2):e34528. doi: 10.7759/cureus.34528. eCollection 2023 Feb. Cureus. 2023. PMID: 36879710 Free PMC article.
-
Calcium pyrophosphate crystal deposition in the temporomandibular joint associated with temporomandibular joint surgery: Case report.Int J Surg Case Rep. 2025 Mar;128:111021. doi: 10.1016/j.ijscr.2025.111021. Epub 2025 Feb 6. Int J Surg Case Rep. 2025. PMID: 39933449 Free PMC article.
References
-
- Rosenthal AK, Ryan LM (2016) Calcium pyrophosphate deposition disease. N Engl J Med 374:2575–2584. https://doi.org/10.1056/nejmra1511117 - DOI - PubMed - PMC
-
- Neame RL, Carr AJ, Muir K, Doherty M (2003) UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 62:513–518. https://doi.org/10.1136/ard.62.6.513 - DOI - PubMed - PMC
-
- Parperis K, Carrera G, Baynes K, Mautz A, Dubois M, Cerniglia R et al (2013) The prevalence of chondrocalcinosis (CC) of the acromioclavicular (AC) joint on chest radiographs and correlation with calcium pyrophosphate dihydrate (CPPD) crystal deposition disease. Clin Rheumatol 32:1383–1386. https://doi.org/10.1136/ard.62.6.513 - DOI - PubMed - PMC
-
- Felson DT, Naimark A, Anderson J, Kazis M, Castelli W, Meenan RF (1987) The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study Arthritis Rheum 30:914–918. https://doi.org/10.1002/art.1780300811 - DOI - PubMed
-
- Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M (1992) Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 22:188–202. https://doi.org/10.1016/0049-0172(92)90019-a - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical